Oliver Hoffmann
Impact in
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies
- Oncology top 5%
- Cancer Cells and Metastasis
- HER2/EGFR in Cancer Research
Papers in
- Oncology 25
- Cancer Cells and Metastasis 11
- HER2/EGFR in Cancer Research 5
- Cancer Treatment and Pharmacology 4
-
- Breast Cancer Treatment Studies 9
- Cancer Genomics and Diagnostics 5
- Co-authors
- Rainer Kimmig (34 shared papers)Sabine Kasimir‐Bauer (27 shared papers)Tanja Natascha Fehm (5 shared papers)Diethelm R. Wallwiener (3 shared papers)Ann‐Kathrin Bittner (30 shared papers)Bahriye Aktas (3 shared papers)Lisa König (4 shared papers)Lale Umutlu (16 shared papers)
- Journals
- Cancers (9 papers)Archives of Gynecology and Obstetrics (4 papers)ESMO Open (4 papers)Journal of Nuclear Medicine (3 papers)Annals of Oncology (3 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Oliver Hoffmann
83 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 107
- Cancer Research 721
- Oncology 1.0k
- Radiology, Nuclear Medicine and Imaging 417
- Pulmonary and Respiratory Medicine 355
- Immunology 165
Countries citing papers authored by Oliver Hoffmann
This map shows the geographic impact of Oliver Hoffmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliver Hoffmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliver Hoffmann more than expected).
Fields of papers citing papers by Oliver Hoffmann
This network shows the impact of papers produced by Oliver Hoffmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliver Hoffmann. The network helps show where Oliver Hoffmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Oliver Hoffmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 85 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 257 | |
| 2 | 2009 | 212 | |
| 3 | 2017 | 111 | |
| 4 | 2019 | 91 | |
| 5 | 2015 | 86 | |
| 6 | 2016 | 73 | |
| 7 | 2016 | 69 | |
| 8 | 2021 | 60 | |
| 9 | 2023 | 56 | |
| 10 | 2021 | 47 | |
| 11 | 2021 | 44 | |
| 12 | 2021 | 43 | |
| 13 | 2021 | 42 | |
| 14 | 2020 | 41 | |
| 15 | 2021 | 40 | |
| 16 | 2019 | 38 | |
| 17 | 2022 | 37 | |
| 18 | 2021 | 36 | |
| 19 | 2020 | 35 | |
| 20 | 2018 | 34 |
About Oliver Hoffmann
Oliver Hoffmann is a scholar working on Oncology, Cancer Research, Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Hematology, having authored 85 papers that have together received 2.2k indexed citations. Recurring topics across this work include Medical Imaging Techniques and Applications (13 papers), Cancer Cells and Metastasis (11 papers), Radiomics and Machine Learning in Medical Imaging (10 papers), Breast Cancer Treatment Studies (9 papers), Advanced Breast Cancer Therapies (7 papers), Cancer Genomics and Diagnostics (5 papers), HER2/EGFR in Cancer Research (5 papers) and Cancer Treatment and Pharmacology (4 papers). The work is most often cited by research in Cancer Research (721 citations), Oncology (1.0k citations), Radiology, Nuclear Medicine and Imaging (417 citations), Pulmonary and Respiratory Medicine (355 citations) and Immunology (165 citations). Oliver Hoffmann has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Rainer Kimmig, Sabine Kasimir‐Bauer, Tanja Natascha Fehm, Diethelm R. Wallwiener, Ann‐Kathrin Bittner, Bahriye Aktas, Lisa König, Lale Umutlu, Sven Becker and Erich Franz Solomayer. Their work appears in journals such as Cancers, Archives of Gynecology and Obstetrics, ESMO Open, Journal of Nuclear Medicine and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.